Answers are grounded in this paper and cite their sources.
Traditionally external quality assessment schemes (EQAS) distribute samples spectrally similar to a normal serum. This does not allow laboratories to assess the performance of their methods at measuring lipaemic samples. The Irish EQAS distributed a sample with a supplied lipid diluent. A sample of the same batch had previously been circulated as a normal distribution to obtain baseline values. Most analytes were affected by the lipaemia. The degree of interference was instrument/method dependent and a wide range of values was reported for each analyte: total protein 51-134 g/L (baseline 65 g/L); albumin 33-56 g/L (baseline 42 g/L); calcium 2.12-6.10 mmol/L (baseline 2.34 mmol/L); urate 38-1100 mumol/L (baseline 195 mumol/L); creatinine 6-199 mumol/L (baseline 140 mumol/L); glucose 4.2-9.5 mmol/L (baseline 4.8 mmol/L); total bilirubin 1-192 mumol/L (baseline 36 mumol/L); urea 1.1-8.1 mmol/L (baseline 3.8 mmol/L); aspartate aminotransferase (AST) 12-105 iu/L (baseline 44 iu/L); iron 4.3-107 mumol/L (baseline 26.8 mumol/L); inorganic phosphorus 1.12-4.96 mmol/L (baseline 1.59 mmol/L); and cholesterol 2.5-17.1 mmol/L (baseline 4.1 mmol/L). In situations where no clearing of the lipid occurs in the reagent, interference can be minimized by taking a sample blank reading or using a kinetic procedure. If clearing of the lipid does occur, time must be allowed for this to be completed before analytical readings are taken.
No takes yet. Share an insight, caveat, or question.
Brady et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: